Published on
September 3, 2025
- 13:30 GMT
Research Finds Post-Approval Cancer Trials Fell After IRA Passage, With Disproportionate Impact on Small Molecule Drugs
Findings highlight concerns of government price regulation and the IRA's "pill penalty." WASHINGTON, DC, UNITED STATES, September 3, 2025 /EINPresswire.com/ -- New research published in Health Affairs Scholar finds that the passage …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
